Dr. Harrington on the KEYNOTE-048 Trial in Recurrent/Metastatic Head and Neck Cancer
Will Immunotherapy Put Head and Neck Surgeons Out of Business? – Semon Lectures
Potential of immunotherapy in head and neck cancer | VJOncology
Radiotherapy Theme on Vimeo
Professor Kevin Harrington - The Institute of Cancer Research, London
The Royal Marsden NHS Foundation Trust on Twitter: "Huge congratulations Professors David Cunningham, Johann De Bono, Kevin Harrington, Nicholas Turner, Mitch Dowsett, James Larkin! #HighlyCited2021" / Twitter
My final lifeline" | The Biomedical Scientist Magazine of the IBMS
Professor Kevin Harrington - The Institute of Cancer Research, London
Dr. Harrington on the KEYNOTE-048 Trial in Recurrent/Metastatic Head and Neck Cancer
Potential of immunotherapy in head and neck cancer | VJOncology
Pablo NENCLARES | Research Fellow | Clinical Oncologist | Head and Neck Unit / Radiotherapy and Imaging Team | Research profile
Game-changing drug doubles head and neck cancer survival | The Royal Marsden
Kevin Harrington (@kevhar6763) / Twitter
PATRIOT: ATR inhibitor monotherapy in advanced solid tumors | VJOncology
Professor Kevin Harrington to star in BBC2's Trust me, I'm a Doctor - The Institute of Cancer Research, London
Professor Kevin Harrington - The Institute of Cancer Research, London
Scientific Advisory Board – PsiVac
RM Magazine - Winter 2022 by The Royal Marsden - Issuu
Royal Marsden researchers named among world's most influential scientists | The Royal Marsden
World-first centre for recurrent head & neck cancer - Professor Christopher Nutting Oncology
GM herpes virus fights advanced cancers
Skin cancer: below the surface | The Royal Marsden
